The one biotech chart that isn't like the rest is Regeneron (REGN). It's actually trading quite well here and has managed to bounce at the 20 day moving average today.
Unfortunately, earnings come Thursday morning and taking a long here is basically a bet on earnings. As a swing trader, that's not an acceptable edge. It'll be interesting to see if this can lead the group higher post earnings. I tend to think not, but who knows.
No comments:
Post a Comment